Becton Dickinson & Co (NYSE:BDX) is a constituent of the 161 company Health Care Equipment & Supplies GICS industry group, which is part of the 782 company GICS Health Care sector. The market value of BDX is $50.1 billion which falls in the top 10% of its industry group. Portfolio Grader's current ranking for BDX puts it 17 among the 161 companies in this industry group, giving it a well above-average position; in the top decile of the sector with a ranking of 46 among the 782 companies in the sector, and number 268 in the nearly 5,000 company Portfolio Grader universe.

Becton Dickinson & Co (NYSE:BDX) is ranked as a Strong Buy using Louis Navellier's approach to investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for the last month.

Becton Dickinson & Co (NYSE:BDX) is one of the 781 companies in the GICS Health Care sector, and a member of the 161 company Health Care Equipment & Supplies GICS industry group within this sector. The market value of BDX is $51.6 billion which places it in the top decile in its industry group. Currently, the stock's Portfolio Grader ranking places it 18 among the 161 companies in this industry group, placing it among the leaders; in the top decile of the sector with a ranking of 55 among the 781 companies in the sector, and number 301 in the nearly 5,000 company Portfolio Grader universe.

Becton Dickinson & Co (NYSE:BDX) is ranked as a Strong Buy using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. BDX has recently seen its Portfolio Grader rating upgraded from a Buy to a Strong Buy.

The current recommendation of Strong Buy for Becton Dickinson & Co (NYSE:BDX) is the result of using the Portfolio Grader stock evaluator, which incorporates Louis Navellier's investing methodology. The shares have been upgraded from a Buy to a Strong Buy in the last week.

Becton Dickinson & Co (NYSE:BDX) is classified as a component of the 164 company Health Care Equipment & Supplies GICS industry group, which is part of the 785 company GICS Health Care sector. The market value of BDX is $51.1 billion which falls in the top 10% of its industry group. The stock's current Portfolio Grader score places it 14 among the 164 companies in this industry group, positioning it among the leaders; among the sector leaders with a ranking of 34 among the 785 companies in the sector, and number 255 in the nearly 5,000 company Portfolio Grader universe.

Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. With exclusive fundamental and quantitative metrics developed by Louis Navellier, this analytical tool researches nearly 5,000 stocks weekly. The current Portfolio Grader recommendation on the shares has been in place for 5 months.

Becton Dickinson & Co (NYSE:BDX) is ranked as a Buy using the system of Louis Navellier for investing and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for 5 months.

Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. The methodology for fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier researches and ranks nearly 5,000 stocks each week. This represents no change from the previous week and is the same ranking BDX has had from Portfolio Grader for 5 months.

Portfolio Grader currently ranks Becton Dickinson & Co (NYSE:BDX) a Buy. The approach to investing incorporated in this analytical tool developed by Louis Navellier researches and ranks nearly 5,000 stocks each week from a fundamental and quantitative perspective. The current Portfolio Grader recommendation on the shares has been in place for 4 months.